Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
51
AMBA Quote, Financials, Valuation and Earnings
Last price:
$74.10
Seasonality move
:
-2.42%
Day range:
$71.26 - $73.33
52-week range:
$39.69 - $81.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.87x
P/B ratio:
5.51x
Volume:
412.7K
Avg. volume:
824.8K
1-year change:
16.81%
Market cap:
$3.1B
Revenue:
$226.5M
EPS (TTM):
-$3.86
Analysts' Opinion
-
Consensus RatingAmbarella has received a consensus rating of . The company's average rating is a based on 5 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $89.55, Ambarella has an estimated upside of 22.35% from its current price of $73.19.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $70.00 representing 100% downside risk from its current price of $73.19.
Fair Value
-
According to the consensus of 0 analysts, Ambarella has 22.35% upside to fair value with a price target of $89.55 per share.
AMBA vs. S&P 500
-
Over the past 5 trading days, Ambarella has underperformed the S&P 500 by -5.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ambarella does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ambarella has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Ambarella reported revenues of $82.7M.
Earnings Growth
-
Ambarella earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Ambarella reported earnings per share of -$0.58.
Enterprise value:
2.8B
EV / Invested capital:
5.10x
Price / LTM sales:
11.87x
EV / EBIT:
--
EV / Revenue:
11.19x
PEG ratio (5yr expected):
-0.69x
EV / Free cash flow:
-753.10x
Price / Operating cash flow:
231.96x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$152.8M
Return On Assets:
-23.85%
Net Income Margin (TTM):
-62.38%
Return On Equity:
-28.04%
Return On Invested Capital:
-28.04%
Operating Margin:
-30.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $344.5M | $258.2M | $252.5M | $50.6M | $82.7M | |
| Gross Profit | $216.6M | $155.6M | $152.8M | $30M | $50M | |
| Operating Income | -$63.2M | -$136.3M | -$143M | -$42M | -$25.5M | |
| EBITDA | -$43.9M | -$112.4M | -$117.3M | -$35.5M | -$19M | |
| Diluted EPS | -$1.67 | -$3.03 | -$3.86 | -$1.04 | -$0.58 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $476.2M | $555.4M | $298.3M | $279.8M | $303.6M | |
| Total Assets | $549.6M | $633.4M | $687.5M | $684.6M | $670.8M | |
| Current Liabilities | $62.2M | $81.6M | $80.9M | $75.8M | $106.9M | |
| Total Liabilities | $86.9M | $104.1M | $99.1M | $92.8M | $116.5M | |
| Total Equity | $462.7M | $529.2M | $588.4M | $591.8M | $554.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $59.6M | $28.1M | $4.4M | $7.9M | $6.6M | |
| Cash From Investing | -$409.6M | -$3.1M | -$27.3M | $13M | -$35.8M | |
| Cash From Financing | $5.1M | $5.9M | $6.2M | $381K | $2.4M | |
| Free Cash Flow | $43.1M | $16.1M | -$3.8M | $5.5M | $4.1M | |
AMBA
Sector
Market Cap
$3.1B
$123.6M
Price % of 52-Week High
90%
67.76%
Dividend Yield
0%
0%
Shareholder Yield
--
1%
1-Year Price Total Return
16.81%
-7.22%
Beta (5-Year)
1.680
0.944
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$72.27
200-day SMA
Buy
Level
$54.81
Bollinger Bands (100)
Buy
Level
49.5 - 66.36
Chaikin Money Flow
Sell
Level
-24M
20-day SMA
Buy
Level
$71.56
Relative Strength Index (RSI14)
Buy
Level
58.83
ADX Line
Buy
Level
10.44
Williams %R
Neutral
Level
-40.2956
50-day SMA
Buy
Level
$63.97
MACD (12, 26)
Buy
Level
2.42
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
57.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.7095)
Buy
CA Score
(Annual)
Level (0.2636)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.9014)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
Stock Forecast FAQ
In the current month, AMBA has received 5 Buy ratings 6 Hold ratings, and 0 Sell ratings. The AMBA average analyst price target in the past 3 months is $89.55.
-
Where Will Ambarella Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ambarella share price will rise to $89.55 per share over the next 12 months.
-
What Do Analysts Say About Ambarella?
Analysts are divided on their view about Ambarella share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ambarella is a Sell and believe this share price will drop from its current level to $70.00.
-
What Is Ambarella's Price Target?
The price target for Ambarella over the next 1-year time period is forecast to be $89.55 according to 0 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is AMBA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ambarella is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of AMBA?
You can purchase shares of Ambarella via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ambarella shares.
-
What Is The Ambarella Share Price Today?
Ambarella was last trading at $74.10 per share. This represents the most recent stock quote for Ambarella. Yesterday, Ambarella closed at $73.19 per share.
-
How To Buy Ambarella Stock Online?
In order to purchase Ambarella stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.12% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.82% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.35% over the past day.
